Levetiracetam Rivopharm Uk

Levetiracetam, the active ingredient in Levetiracetam Rivopharm Uk, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients diagnosed with epilepsy. The medication works by modulating neuronal activity, helping to reduce the frequency and severity of seizure episodes.

GNH USA supplies Levetiracetam Rivopharm Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and healthcare institutions worldwide across major markets.

Levetiracetam is an antiepileptic drug used to control various seizure types.

Partial (focal) seizures: provides significant reduction in seizure frequency and severity for patients with focal onset epilepsy. Generalized tonic‑clonic seizures: helps prevent convulsive seizures in individuals with generalized epilepsy, improving overall seizure control. Myoclonic seizures: decreases the occurrence of sudden, brief muscle jerks characteristic of myoclonic epilepsy, enhancing daily functioning. Adjunctive therapy: can be combined with other antiepileptic medications to achieve better seizure management when monotherapy is insufficient.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Somnolence - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or angioedema - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts, depression, or other significant psychiatric changes

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests regularly. - Psychiatric history: observe for mood changes, depression, or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: strong enzyme inducers that markedly reduce levetiracetam plasma concentrations. - Rifampicin: induces metabolism leading to decreased drug levels.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring monitoring. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception. - Fluconazole: moderate inhibitor may slightly raise levetiracetam concentrations.